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Jefferson Cancer Center Officially Recognized by the 
National Cancer Institute 
With the awarding on June 22, 1995 of a Cancer Center Support Grant (CCSG), the 
NIH National Cancer Institute (NCI) officially recognized the Jefferson Cancer Center 
as one of only 54 NCI designated cancer centers in the United States. This grant was 
awarded for an initial period of three years in the aggregate amount of $3,472,327. 
The CCSG is intended to provide an organizational stimulus for the highest quality 
interdisciplinary cancer research, and to take maximum advantage of scientific 
opportunities and institutional resources to accelerate the movement of basic 
research findings into applied research toward the reduction of cancer incidence, 
morbidity and mortality.  
The Jefferson Cancer Center is one of the leading clinical cancer research institutions 
in the nation, with externally funded cancer research projects amounting to more 
than $30 million per year. It is organized into five established basic science research 
programs: Cell Biology, Signal Transduction, Molecular Biology and Genetics, 
Structural Biology, and Immunology; three established clinical research programs: 
Developmental Therapeutics, Melanoma, and Leukemia/Lymphoma; and 
developmental programs in prostate, gastrointestinal and breast cancers. The Cancer 
Center also trains graduate students in cancer research in four programs: Genetics, 
Immunology, Microbiology and Molecular Virology, and Molecular Pharmacology and 
Structural Biology.  
Carlo M. Croce, MD, Professor and Chairman of Microbiology and Immunology, is the 
Director of the Cancer Center, and its Clinical Director is Robert L. Comis, MD, the 
Ludwig A. Kind Professor and Director of the Division of Neoplastic Diseases, 
Department of Medicine. The interdisciplinary nature of the Cancer Center is 
demonstrated by the fact that its active faculty membership is drawn from the 
departments of Microbiology and Immunology, Pharmacology, Biochemistry and 
Molecular Biology, Dermatology, Medicine, Otolaryngology, Pathology, Radiation 
Oncology and Nuclear Medicine, Radiology, Surgery, and Urology. While the majority 
of the research laboratories of the Cancer Center are located in the Bluemle Life 
Sciences Building, clinical trials and patient care activities are carried out in the 
University Hospital and in the participating Jefferson Cancer Network hospitals. 
Among the studies currently in progress are clinical trials of breast, genitourinary, 
gastrointestinal, gynecologic, lung, CNS primary cancers, melanoma, sarcoma, and 
studies of blood flow in tumors during local hyperthermia. Young scientists from 
around the world are also attracted to the Cancer Center, coming here for several 
years to learn the intellectual approaches and laboratory techniques of cancer 
research for application in their native lands.  
There are two other designated cancer centers in the Delaware Valley: the Fox Chase 
Cancer Center and the University of Pennsylvania Cancer Center. 
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